New executive vice president appointed at Nycomed

Anders Ullman has been appointed to lead Nycomed’s research and development function upon approval and completion of the deal to purchase ALTANA Pharma.

Anders Ullman has a 16 year track record of medical research and development, most recently as Senior Vice President, Research & Development, at the European biopharma company Biovitrum.

“With the head of R&D in place, the Executive Committee for the new Nycomed is set. This gives us the possibility to join ALTANA Pharma and Nycomed together as soon as all the approvals are received from authorities and shareholders,” said Håkan Björklund, Nycomed CEO.
 
The new Executive Committee will be effective from the closing of the deal to purchase ALTANA Pharma expected by the year end.

Source: Press-release, Nycomed 01.12.2006.

Read more at the homepage of Nycomed.